⌘K

Login Start Free

Home/Filings/4/0001415889-16-006515

4//SEC Filing

INNOVUS PHARMACEUTICALS, INC. 4

Accession 0001415889-16-006515

CIK 0001411879operating

View on SEC.gov Company Profile

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 9:50 PM ET

Size

7.4 KB

Accession

0001415889-16-006515

Insider Transaction Report

Form 4

Period: 2016-04-04

INNOVUS PHARMACEUTICALS, INC.INNV

Director

Transactions

Award
Restricted Stock Units
2016-04-01$0.07/sh+44,709$3,000→ 1,138,907 total
From: 2016-04-01Exp: 2026-04-01→ Common Stock (44,709 underlying)
Award
Restricted Stock Units
2016-07-01$0.21/sh+13,825$2,913→ 1,152,732 total
From: 2016-07-01Exp: 2026-07-01→ Common Stock (13,825 underlying)

Footnotes (1)

[F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Documents

1 file

4
form4-07152016_090711.xmlPrimary

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001411879

Filing Metadata

Form type: 4
Filed: Jul 14, 8:00 PM ET
Accepted: Jul 15, 9:50 PM ET
Size: 7.4 KB

View on SEC.gov